DXCM vs XRX · P/E 63, rev $2.50B vs rev $1.92B
DexCom Inc (DXCM) versus Xerox Corp (XRX) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Xerox Corp (XRX) is a business equipment & supplies company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported XRX revenue for 2026-06-30 was $1.92B. Net income was $13.0M. Revenue was up 4.1% from 2026-03-31 to 2026-06-30. XRX currently screens at market cap $410.6M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. XRX currently screens at market cap $410.6M.
Not investment advice. Open the DXCM and XRX stock pages for the full models.
Not investment advice.